This website uses cookies to enhance the user experience.
||
M

MUNDIPHARMA AS982 188 768

Purchase and sale
Limited company
3. etasje Lysaker torg 5 1366 LYSAKER, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

MUNDIPHARMA AS

Operating
Forskning og utvikling, registrering, markedsføring, distribusjon og salg av farmasøytiske preparater, herunder handel med kjemikalier, toalettsaker og kosmetikk, samt legemidler. Formålet omfatter også import, eksport og produksjon, herunder engasjement av kontraktprodusenter for lokal produksjon.
Forskning, utvikling, produksjon og handel med farmasøytiske produkter.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
LK

Lisbeth Kattenhøj1967

Chairman of the board
SJ

Stephen Johan Jamieson1957

Years since formation
25 years
since Aug 3, 2000
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
227
3 share classes
Total number of shareholders
4
persons

Financials

Total operating income 2024
72,153,326
NOK
Annual total result 2024
1,881,322
NOK
Total equity 2024
22,024,174
NOK
Last update: Sep 9, 2025

Management

Management / administration

NameRoleShares
LK

Lisbeth Kattenhøj

1967

Managing Director/CEO-

Board

NameRoleShares
SJ

Stephen Johan Jamieson

1957

Chairman-
LK

Lisbeth Kattenhøj

1967

Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
G
GRANT THORNTON ØKONOMISERVICE AS
Accountant-
Last update: Aug 29, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
SN

Sarl Nontag

C-shares
88
38.77 %
BS

Bv Sarl Halm

A-shares
50
22.03 %
MC

Medical Company Lp Rosebay

Class B shares
50
22.03 %
HS

Holdings Sarl Lymit

C-shares
39
17.18 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
72,153,326
63,137,861
69,658,842
81,993,894
Annual Total Result
1,881,322
1,446,967
1,661,061
1,962,920
Total assets
100,115,765
114,116,447
92,399,222
79,138,200
Total liabilities
78,091,591
93,973,595
31,031,337
19,431,375
Total equity
22,024,174
20,142,853
61,367,886
59,706,825

P&L

Year2024202320222021
Total operating income
72,153,326
63,137,861
69,658,842
81,993,894
Total operating costs
70,400,613
61,210,528
67,382,448
79,614,885
Operating result
1,752,713
1,927,333
2,276,394
2,379,009
Financial income/costs
656,791
-70,344
-146,827
138,983
Profit before tax
2,409,504
1,856,989
2,129,567
2,517,992
Total tax & extraordinary income/cost
528,182
410,022
468,506
555,072
Annual Total Result
1,881,322
1,446,967
1,661,061
1,962,920

Balance overview

Year2024202320222021
Total fixed assets
2,909,864
1,075,771
930,580
439,235
Total current assets
97,205,901
113,040,676
91,468,642
78,698,965
Total assets
100,115,765
114,116,447
92,399,222
79,138,200
Short term debt
78,091,591
93,973,595
31,031,337
19,431,375
Long term debt
0
0
0
0
Total liabilities
78,091,591
93,973,595
31,031,337
19,431,375
Contributed capital
227,000
227,000
227,000
227,000
Retained earnings
21,797,174
19,915,853
61,140,886
59,479,825
Total equity
22,024,174
20,142,853
61,367,886
59,706,825
Total equity and liabilities
100,115,765
114,116,447
92,399,222
79,138,200

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods